Sign in →

Test Code LAB4095 GENTAMICIN LEVEL, RANDOM

Specimen Type

Preferred Sample: Lithium Heparin Plasma (Mint Green Top, Dark Green Top)
Alternative Sample: Serum (SST, Gold, Corvac, Tiger, Red Top Tube)

Specimen Volume

1 mL

Minimum Volume

0.5 mL

Turnaround Time

STAT: 1 hour
Routine: 4 hours

Test Schedule

Daily

Method

Colorimetric

Reference Ranges

Gentamicin µg/mL:

        Random: <10.0

        Trough 0.5 – 2.0

        Trough Toxic: >2.0

        Peak 5.0 – 10.0

        Peak Toxic: >12.0

Synonyms

Garamycin, Single

CPT Codes

80170

Test Components

Gentamicin, µg/mL

Test Limitations

Studies have shown that therapeutic drug levels may be altered in serum/plasma that remains in contact with separator gel. Therapeutic drug levels collected in an SST or PST should be run within 24 hrs of collection.

Specimen Processing

Remove the plasma or serum from the cells, clot or gel as soon as possible before storing.

Specimen Stability

Refrigerated: 7 days

Frozen: 14 days

Clinical Information

Gentamicin is used in the treatment of serious infections involving aminoglycoside-sensitive organisms. Monitoring gentamicin concentration in serum or plasma, along with careful clinical assessment, is the most effective means of ensuring adequate therapy. Gentamicin concentration correlates better with antibacterial activity than dosage. A standard dose of gentamicin does not always yield a predictable concentration as the drugs concentration depends on the patient’s volume of distribution and on drug elimination. These factors are influenced by the mode of administration, the volume of extracellular fluid, renal retention, and physiological changes during therapy. Gentamicin has a narrow range of safe and effective concentration.

 

Exposure to high concentrations for a prolonged period may cause renal impairment or ototoxicity. Patients with impaired renal function should be monitored closely while on gentamicin therapy due to nephrotoxicity caused by gentamicin may be difficult to distinguish from symptoms of underlying renal disease.